Ethical qualms about genetic prognosis

Interview with Donna Dickenson, emeritus professor of medical ethics and humanities at the University of London. Consumer genetic testing, and subsequent personalized medicine are, by some accounts, the harbingers of a revolution in medicine. In the sphere of pharmacology, this conceit has ethical and practical implications, says international ethics expert Donna Dickenson.Full article: https://www.cmaj.ca/lookup/doi/10.1503/cmaj.151320To request a transcript of this podcast, contact cmajgroup@cmaj.caSubscribe to CMAJ Podcasts on Apple Podcasts or your favourite podcast app. You can also follow us directly on our SoundCloud page or you can visit www.cmaj.ca/page/multimedia/podcasts.

Comments or questions? Text us.

Join us as we explore medical solutions that address the urgent need to change healthcare. Reach out to us about this or any episode you hear. Or tell us about something you'd like to hear on the leading Canadian medical podcast.

You can find Blair and Mojola on X @BlairBigham and @Drmojolaomole

X (in English): @CMAJ
X (en français): @JAMC
Facebook
Instagram: @CMAJ.ca

The CMAJ Podcast is produced by PodCraft Productions